These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 26140091)

  • 21. Clinicopathologic characteristics andoutcomes of hepatocellular carcinoma associated with chronic hepatitis B versus hepatitis C infection.
    Aljumah AA; Kuriry H; Faisal N; Alghamdi H
    Ann Saudi Med; 2018; 38(5):358-365. PubMed ID: 30284991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes mellitus, metabolic syndrome and obesity are not significant risk factors for hepatocellular carcinoma in an HBV- and HCV-endemic area of Southern Taiwan.
    Chen CT; Chen JY; Wang JH; Chang KC; Tseng PL; Kee KM; Chen PF; Tsai LS; Chen SC; Lin SC; Lu SN
    Kaohsiung J Med Sci; 2013 Aug; 29(8):451-9. PubMed ID: 23906236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide.
    Kim DY
    J Liver Cancer; 2024 Mar; 24(1):62-70. PubMed ID: 38523466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Etiological and molecular profile of hepatocellular cancer from India.
    Asim M; Sarma MP; Kar P
    Int J Cancer; 2013 Jul; 133(2):437-45. PubMed ID: 23233429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma epidemiology.
    Bosetti C; Turati F; La Vecchia C
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):753-70. PubMed ID: 25260306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hepatitis B surface antigen and HCV antibodies in hepatocellular carcinoma cases in Karachi, Pakistan.
    Abdul Mujeeb S; Jamal Q; Khanani R; Iqbal N; Kaher S
    Trop Doct; 1997 Jan; 27(1):45-6. PubMed ID: 9030022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
    Abruzzi A; Fried B; Alikhan SB
    Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area.
    Cho EJ; Kwack MS; Jang ES; You SJ; Lee JH; Kim YJ; Yoon JH; Lee HS
    Digestion; 2011; 84 Suppl 1():17-22. PubMed ID: 22156481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Review of Incidence and Related Risk Factors in the Development of Hepatocellular Carcinoma.
    Lampimukhi M; Qassim T; Venu R; Pakhala N; Mylavarapu S; Perera T; Sathar BS; Nair A
    Cureus; 2023 Nov; 15(11):e49429. PubMed ID: 38149129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence.
    Donato F; Gelatti U; Limina RM; Fattovich G
    Oncogene; 2006 Jun; 25(27):3756-70. PubMed ID: 16799617
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epidemiology of Hepatocellular Carcinoma in the Asia-Pacific Region.
    Zhu RX; Seto WK; Lai CL; Yuen MF
    Gut Liver; 2016 May; 10(3):332-9. PubMed ID: 27114433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
    Tunissiolli NM; Castanhole-Nunes MMU; Pavarino ÉC; da Silva RF; da Silva RCMA; Maria Goloni-Bertollo E
    Asian Pac J Cancer Prev; 2018 Oct; 19(10):2795-2802. PubMed ID: 30360608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
    Kao JH
    Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving survival in patients with hepatocellular carcinoma related to chronic hepatitis C and B but not in those related to non-alcoholic steatohepatitis or alcoholic liver disease: a 20-year experience from a national programme.
    Hassan I; Gane E
    Intern Med J; 2019 Nov; 49(11):1405-1411. PubMed ID: 30908822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000-2014).
    Waziry R; Grebely J; Amin J; Alavi M; Hajarizadeh B; George J; Matthews GV; Law M; Dore GJ
    J Hepatol; 2016 Dec; 65(6):1086-1093. PubMed ID: 27569777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review article: the prevention of hepatitis B-related hepatocellular carcinoma.
    Lin CL; Kao JH
    Aliment Pharmacol Ther; 2018 Jul; 48(1):5-14. PubMed ID: 29722445
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Global trends and predictions in hepatocellular carcinoma mortality.
    Bertuccio P; Turati F; Carioli G; Rodriguez T; La Vecchia C; Malvezzi M; Negri E
    J Hepatol; 2017 Aug; 67(2):302-309. PubMed ID: 28336466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The continuing challenge of hepatic cancer in Asia.
    Lai EC; Lau WY
    Surgeon; 2005 Jun; 3(3):210-5. PubMed ID: 16076007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.